GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report)’s share price traded down 11.3% during mid-day trading on Friday . The company traded as low as $0.10 and last traded at $0.11. 19,500 shares changed hands during mid-day trading, an increase of 133% from the average session volume of 8,378 shares. The stock had previously closed at $0.13.
GeoVax Labs Price Performance
The company’s 50 day moving average is $0.12 and its 200 day moving average is $0.16.
About GeoVax Labs
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
See Also
- Five stocks we like better than GeoVax Labs
- Dividend Payout Ratio Calculator
- Nebius Group: Market Overreaction or Real AI Disruption?
- What is Forex and How Does it Work?
- The Best Way to Invest in Gold Is…
- How to Calculate Stock Profit
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
